Details of the Drug
General Information of Drug (ID: DMW180Y)
| Drug Name |
Glycinamide Ribonucleotide
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Glycineamide ribonucleotide; Glycineamideribotide; glycinamide ribonucleotide; 10074-18-7; 5'-phosphoribosylglycineamide; GAR; 5'-phosphoribosylglycinamide; N1-(5-Phospho-D-ribosyl)glycinamide; {[(2R,3S,4R,5R)-5-(2-aminoacetamido)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid; N1-(5-phospho-beta-D-ribosyl)glycinamide; Glycineamide ribotide; AC1Q5JNA; AC1L4OGM; n-glycyl-5-o-phosphono-; A-d-ribofuranosylamine; 5'-Phosphoribosyl-glycineamide; SCHEMBL4366354; BDBM22589; DTXSID70143478; C03838
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 2 | Molecular Weight (mw) | 286.18 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | -6.8 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 5 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 6 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 9 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


